Cantor Fitzgerald Reaffirms Overweight Rating on CVS Health (CVS)

Core Insights - CVS Health Corporation is recognized as one of the 11 Defensive Healthcare Dividend Stocks to consider for investment [1] - Cantor Fitzgerald has reaffirmed an Overweight rating on CVS Health, noting the stock has increased by over 80% since the beginning of 2025 [2] - The slight decline in Medicare Advantage Star ratings was viewed as "more positive than feared," with CVS maintaining over 80% of its ratings at high levels, indicating a favorable market reaction is expected [3] Financial Performance - CVS Health's quarterly dividend is set at $0.665 per share, yielding 3.35% as of October 14, reflecting a consistent payout record since 1997 [5] Market Position - Concerns regarding CVS's ability to sustain its strong position in the Medicare Star Ratings program were noted, which is crucial for determining reimbursement rates and enrollment opportunities for Medicare Advantage plans [4]